Meningoencephalitis with Aspergillus and Mycobacterium Tuberculosis in a renal transplant recipient

Experimental and Clinical Transplantation

Volumn 9, Issue 1, 2011, Pages 68-71

  Petramfar, Peyman ^a   Yousefian, Marzieh ^a   Ashraf, Mohammad Hosein ^b   Davarpanah, Mohammad Ali ^c   Rahmati, Hashem ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aspergillosis; Central nervous system; Solid organ transplant; Tuberculosis

Indexed keywords

AMPHOTERICIN; CEFTRIAXONE; CYCLOSPORIN; ETHAMBUTOL; ISONIAZID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLUS; CASE REPORT; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; DEATH; DETERIORATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GRAFT RECIPIENT; HUMAN; IMAGE ANALYSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LUMBAR PUNCTURE; MENINGOENCEPHALITIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; SPLENOMEGALY; TREATMENT DURATION; WEAKNESS;

ADULT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTITUBERCULAR AGENTS; ASPERGILLUS; BACTERIOLOGICAL TECHNIQUES; CYCLOSPORINE; DNA, BACTERIAL; DNA, FUNGAL; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MENINGOENCEPHALITIS; MYCOBACTERIUM TUBERCULOSIS; MYCOPHENOLIC ACID; POLYMERASE CHAIN REACTION; PREDNISOLONE; TREATMENT FAILURE; TUBERCULOSIS, MENINGEAL;

EID: 79952673012     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Torre-Cisneros J, Lopez OL, Kusne S, et al. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1993;56(2):188-193
2. Papagianni A, Alexopoulos E, Visvardis G, Vakianis P, Papadimitriou M. Tuberculous meningoencephalitis after cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1994;9(4):438-442.
3. Grauhan O, Lohmann R, Lemmens P, et al. Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995;380(3):171-175.
4. Mondol BA, Siddiqui MR, Mohammad QD, et al. Tuberculosis of the central nervous system. Mymensingh Med J. 2010;19(2):312-322
5. Coates M, Wilson J. Central nervous system aspergillus infection complicating renal transplantation. Australas Radiol. 2001;45(3):338-342.
6. Dil-Afroze, Abdul Waheed Mir, Altaf Kirmani, Shakeel-ul-Rehman, Rafiqa Eachkoti, Mushtaq A. Siddiqi. Improved diagnosis of central nervous system tuberculosis by MPB64-Target PCR. Braz J Microbiol. 2008;39(2):209-213
7. Parisa Badiee, Abdolvahab Alborzi, Elaheh Shakiba, Mazyar Ziyaeyan, Bahman Pourabbas. Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J Med Microbiol. 2009;58:192-195
8. Zhang XF, Lv Y, Xue WJ, et al. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China. Transplant Proc. 2008;40(5):1382-1385
9. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4(3):160-170
10. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633-643
11. Kumar R, Kohli N, Thavnani H, Kumar A, Sharma B. Value of CT scan in the diagnosis of meningitis. Indian Pediatr. 1996;33(6):465-468
12. [No authors listed]. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 1998;53(7):536- 548.
13. Boon AP, Adams DH, Buckels J, McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol. 1990;43(2):114-118
14. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40(12):1762-1769
15. Buchheidt D, Hummel M. Aspergillus polymerase chain reaction (PCR) diagnosis. Med Mycol. 2005;43(suppl 1):S139-S145.
16. Millon L, Grenouillet F, Crouzet J, et al.False-positive Aspergillus realtime PCR assay due to a nutritional supplement in a bone marrow transplant recipient with GVH disease. Med Mycol. 2010;48(4):661- 664.
17. Sun YQ, Ji Y, Xu LP, Liu DH, Liu KY, Huang XJ. Combination of realtime polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation [in Chinese]. Zhonghua Yi Xue Za Zhi. 2010 9;90(6):375-378
18. Miaux Y, Ribaud P, Williams M, et al. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. AJNR Am J Neuroradiol. 1995;16(3):555-562
19. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26(4):781- 803; quiz 804-805
20. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415